Nilofer Azad

Associate Professor

19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Nilofer Azad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Rectal Neoplasms Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

An analysis of genetic heterogeneity in untreated cancers

Reiter, J. G., Baretti, M., Gerold, J. M., Makohon-Moore, A. P., Daud, A., Iacobuzio-Donahue, C. A., Azad, N., Kinzler, K. W., Nowak, M. A. & Vogelstein, B., Jan 1 2019, (Accepted/In press) In : Nature Reviews Cancer.

Research output: Contribution to journalArticle

Genetic Heterogeneity
Mutation
Neoplasms
Neoplasm Metastasis
Genes

A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors

Gaillard, S., Zahurak, M., Sharma, A., Reiss, K. A., Sartorius-Mergenthaler, S., Downs, M., Anders, N. M., Anders, N., Ahuja, N. & Azad, N., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Methyltransferases
Long Interspersed Nucleotide Elements
DNA
Neoplasms

A phase i trial of the VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced solid tumors and differentiated thyroid cancers

Kurzrock, R., Ball, D. W., Zahurak, M. L., Nelkin, B. D., Subbiah, V., Ahmed, S., O'Connor, A., Karunsena, E., Parkinson, R., Bishop, J. A., Ha, Y., Sharma, R., Gocke, C., Zinner, R., Rudek-Renaut, M., Sherman, S. I. & Azad, N., Sep 15 2019, In : Clinical Cancer Research. 25, 18, p. 5475-5484 10 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor
Mitogen-Activated Protein Kinase Kinases
Thyroid Neoplasms
Protein-Tyrosine Kinases
Neoplasms

Corrigendum: Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer (Annals of Oncology (2018) 29 (139-144) DOI: 10.1093/annonc/mdx688)

Overman, M. J., Adam, L., Raghav, K., Wang, J., Kee, B., Fogelman, D., Eng, C., Vilar, E., Shroff, R., Dasari, A., Wolff, R., Morris, J., Karunasena, E., Pisanic, T. R., Azad, N. & Kopetz, S., Mar 1 2019, In : Annals of Oncology. 30, 3, 1 p.

Research output: Contribution to journalComment/debate

Open Access
CpG Islands
Names
Colorectal Neoplasms
Adenocarcinoma
Phenotype

Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer

Russo, S., Anker, C. J., Abdel-Wahab, M., Azad, N., Bianchi, N., Das, P., Dragovic, J., Goodman, K. A., Jones, W., Kennedy, T., Kumar, R., Lee, P., Sharma, N., Small, W., Suh, W. W. & Jabbour, S. K., Nov 1 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 3, p. 591-605 15 p.

Research output: Contribution to journalReview article

Anus Neoplasms
cancer